Maya Laprade, DO Hospitalist Medicare: Medicare Enrolled Practice Location: 201 N Clyde Morris Blvd Ste 200, Daytona Beach, FL 32114 Phone: 386-425-4165 Fax: 386-425-4165 |
Dr. Corey Michael Burns, DO Hospitalist Medicare: Medicare Enrolled Practice Location: 201 N Clyde Morris Blvd Ste 200, Daytona Beach, FL 32114 Phone: 386-425-4167 Fax: 386-425-7545 |
Kari Stausmire, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 201 N Clyde Morris Blvd Ste 200, Daytona Beach, FL 32114 Phone: 386-425-4165 Fax: 386-425-7545 |
Monica J Davis, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 303 N Clyde Morris Blvd, Daytona Beach, FL 32114 Phone: 386-226-4542 |
News Archive
Study investigators reported positive steps in Cook Medical's efforts to gain FDA approval of the treatment assessed in the STABLE clinical trial, designed to evaluate the safety and efficacy of a proximal endograft and a distal uncovered stent for the endovascular treatment of Type B aortic dissection for purposes of seeking FDA approval. The findings were presented by Dr. Joseph Lombardi at the 37th annual VEITHsymposium.
An international research team led by medical scientists at the University of Alberta has shown that new medications based on resveratrol - a compound found in red wine and nuts - may be used to treat a common heart-rhythm problem known as atrial fibrillation.
People with autism often experience hypersensitivity to noise and other sensory input. MIT neuroscientists have now identified two brain circuits that help tune out distracting sensory information, and they have found a way to reverse noise hypersensitivity in mice by boosting the activity of those circuits.
Spectranetics Corporation, a medical device manufacturer, has agreed to pay the United States $4.9 million in civil damages plus a $100,000 forfeiture to resolve claims against the company, the Justice Department announced today. The claims arise from allegations that the company illegally imported unapproved medical devices and provided them to physicians for use in patients, conducted a clinical study in a manner that failed to comply with federal regulations and promoted certain products for procedures for which the company had not received Food and Drug Administration approval or clearance.
The world's pioneering researchers in robotic surgery are invited to showcase their innovative work by taking part in the Surgical Robot Challenge 2016. The Surgical Robot Challenge is open for entry from today, and the competition finals will be held from 20 – 27 June 2016 at the Hamlyn Symposium on Medical Robotics in London, as part of the first ever UK Robotics Week.
› Verified 4 days ago